Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 11 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (5)
P 3 (1)
P 4 (2)

Trial Status

Completed6
Recruiting3
Active Not Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (11)

Research Network

Activity Timeline